We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+69.67%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.08B
AUM Growth
+$396M
(+23%)
Cap. Flow
-$317M
Cap. Flow
% of AUM
-15.21%
Top 10 Holdings %
Top 10 Hldgs %
80.63%
Holding
42
New
6
Increased
4
Reduced
3
Closed
12
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
+$53.8M |
| 2 |
BBOT
BridgeBio Oncology
BBOT
|
+$29.4M |
| 3 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$20.2M |
| 4 |
MBX
MBX Biosciences
MBX
|
+$13M |
| 5 |
Aquestive Therapeutics
AQST
|
+$11.3M |
Top Sells
| 1 |
APLS
Apellis Pharmaceuticals
APLS
|
+$197M |
| 2 |
ITOS
iTeos Therapeutics
ITOS
|
+$107M |
| 3 |
Janux Therapeutics
JANX
|
+$34M |
| 4 |
Kura Oncology
KURA
|
+$23.7M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$23.5M |
Sector Composition
| 1 | Healthcare | 99.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zymeworks
ZYME
$1.81B
| $392M | 18.83% |
22,970,388
| – | – |
|
2
AnaptysBio
ANAB
$1.65B
| $241M | 11.58% |
7,880,094
| – | – |
|
3
uniQure
QURE
$2.82B
| $233M | 11.17% |
3,988,971
| – | – |
|
4
Jazz Pharmaceuticals
JAZZ
$15B
| $225M | 10.79% |
1,706,469
| – | – |
|
5
Crinetics Pharmaceuticals
CRNX
$8.88B
| $179M | 8.57% |
4,288,120
| – | – |
|
6
CRISPR Therapeutics
CRSP
$5.06B
| $90M | 4.32% |
1,389,276
| – | – |
|
7
Tango Therapeutics
TNGX
$4.93B
| $89.3M | 4.29% |
10,630,736
| – | – |
|
|
8
Oric Pharmaceuticals
ORIC
$1.15B
| $80.7M | 3.87% |
6,728,116
+5,110,048
| +316% | +$53.8M |
|
|
APLS
9
DELISTED
Apellis Pharmaceuticals
APLS
| $78M | 3.74% |
3,447,156
-8,448,652
| -71% | -$197M |
|
10
Xencor
XNCR
$1.11B
| $72.1M | 3.46% |
6,144,767
| – | – |
|
|
LKFT
11
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $57.7M | 2.77% |
1,667,119
+630,174
| +61% | +$20.2M |
|
12
Immunome
IMNM
$2.6B
| $47.8M | 2.29% |
4,079,415
| – | – |
|
13
Eton Pharmaceutcials
ETON
$1.05B
| $44.1M | 2.12% |
2,030,544
| – | – |
|
|
MBX
14
MBX Biosciences
MBX
$2.89B
| $37.2M | 1.78% |
2,123,604
+973,810
| +85% | +$13M |
|
15
Madrigal Pharmaceuticals
MDGL
$12.7B
| $34.4M | 1.65% |
75,000
| – | – |
|
|
RNAM
16
DELISTED
Avidity Biosciences
RNAM
| $33.3M | 1.6% |
765,000
+265,000
| +53% | +$10.7M |
|
|
BBOT
17
BridgeBio Oncology
BBOT
$674M
| $32.7M | 1.57% |
+2,823,126
| New | +$29.4M |
|
18
Neurogene
NGNE
$787M
| $22M | 1.06% |
1,271,342
| – | – |
|
19
Alkermes
ALKS
$8.66B
| $15M | 0.72% |
500,000
| – | – |
|
|
20
Aquestive Therapeutics
AQST
$496M
| $14.7M | 0.7% |
+2,625,000
| New | +$11.3M |
|
|
MTSR
21
DELISTED
Metsera Inc
MTSR
| $14.2M | 0.68% |
271,529
| – | – |
|
|
CNTA
22
DELISTED
Centessa Pharmaceuticals
CNTA
| $13.3M | 0.64% |
+550,000
| New | +$9.78M |
|
23
Prime Medicine
PRME
$629M
| $8.55M | 0.41% |
+1,543,326
| New | +$6.27M |
|
24
Atara Biotherapeutics
ATRA
$77M
| $8.21M | 0.39% |
573,183
| – | – |
|
|
25
Kura Oncology
KURA
$1.01B
| $7.72M | 0.37% |
872,500
-3,327,500
| -79% | -$23.7M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM